YUANLI(SH:603217)2021-04-27 16:00Financial Performance - Operating revenue surged by 84.57% to CNY 458,992,011.67 year-on-year[5] - Net profit attributable to shareholders increased by 192.81% to CNY 81,986,121.00 compared to the same period last year[5] - Basic earnings per share reached CNY 0.643, up 192.27% from CNY 0.22 in the previous year[5] - The total profit for the current period was ¥96,038,418.12, which is a 187.34% increase compared to ¥33,423,830.05 in the same period last year[13] - Net profit for Q1 2021 was RMB 81,986,121.00, up 192.5% from RMB 28,000,226.99 in Q1 2020[28] - The company's operating revenue for Q1 2021 reached ¥458,992,011.67, an increase of 84.57% compared to ¥248,681,814.36 in the same period last year[13] Cash Flow - Net cash flow from operating activities rose by 26.90% to CNY 50,312,358.78 year-on-year[5] - The net cash flow from investing activities improved significantly to ¥215,049,963.89, compared to a negative cash flow of ¥62,870,165.81 in the previous year[13] - Cash inflow from operating activities increased to ¥257,727,995.69 in Q1 2021, up from ¥151,956,753.41 in Q1 2020, representing a growth of approximately 69.5%[38] - The net cash flow from investment activities was ¥215,049,963.89, a turnaround from a negative cash flow of -¥62,870,165.81 in the same period last year[35] Assets and Liabilities - Total assets increased by 10.63% to CNY 2,829,649,974.30 compared to the end of the previous year[5] - Cash and cash equivalents increased by 156.42% to CNY 512,314,782.41 compared to the previous year-end[10] - Total liabilities increased to ¥488,843,118.63, compared to ¥298,831,354.80 in the previous year, indicating a rise in financial obligations[21] - Total current assets amounted to approximately 1.50 billion, with cash and cash equivalents at approximately 122.75 million and accounts receivable at approximately 99.28 million[44] Shareholder Information - The number of shareholders totaled 14,393 at the end of the reporting period[8] - The company's equity attributable to shareholders was ¥2,258,906,808.69, indicating a stable equity position[42] Research and Development - Research and development expenses surged to ¥19,329,671.10, up 122.35% from ¥8,693,389.14 in the previous year, reflecting increased investment in R&D[13] - Research and development expenses increased to ¥17,219,569.01, up 97.5% from ¥8,693,389.14 in the same period last year[31] Future Outlook - The company plans to expand its market presence and enhance product development strategies in the upcoming quarters[10] - The company anticipates a significant increase in cumulative net profit for the year compared to the previous year, although this projection carries considerable uncertainty[15] - Future guidance indicates a positive outlook for revenue growth, driven by increased demand for its products and services[46]